Navigation Links
New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Disease
Date:6/2/2009

First-of-its-Kind Study Demonstrates REMICADE More Likely to Maintain Steroid-Free Remission in Patients Naive to Immunomodulators and BiologicTherapy

CHICAGO, June 2 /PRNewswire/ -- New long-term findings from the Phase 3b study of patients with moderately to severely active Crohn's disease having inadequate response to conventional therapies, but naive to immunomodulators and biologic therapy, were presented at Digestive Disease Week today. Data from the SONIC study showed that a greater proportion of patients receiving REMICADE (infliximab) maintained steroid-free remission at one year, compared with patients receiving azathioprine alone.

"The new, year-long data reinforce earlier 26 week findings from the SONIC trial and support the importance of this first-of-its-kind study for treating Crohn's disease," said Dr. Jean-Frederic Colombel, Professor of Hepatogastroenterology, Centre Hospitalier Universitaire Lille, France, study investigator. "The data further support the use of REMICADE earlier in the treatment of moderate to severe Crohn's disease and its effectiveness in patients maintaining steroid-free remission through one year."

The SONIC clinical trial is the first of its kind to compare REMICADE, an anti-tumor necrosis factor (TNF)-alpha therapy, with an immunomodulator (azathioprine) in patients with moderate to severe Crohn's disease. Azathioprine is not approved by the U.S. Food and Drug Administration (FDA) for the treatment of Crohn's disease; however, it is widely used by gastroenterologists and other physicians in the United States to treat patients with Crohn's disease. Azathioprine is approved for the treatment of Crohn's disease in some countries outside the United States.

Patients participating in the SONIC study through 30 weeks were given the option of continuing in a blinded study extension through 54 weeks. The proportion of patients achieving steroid-free rem
'/>"/>

SOURCE Centocor Ortho Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
2. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
3. Results From One-Year Study Suggest Advair(R) Provides Important Benefits for African American Patients With Asthma
4. Data from One-Year Liraglutide Phase 3 Study Published Online in The Lancet
5. New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease
6. New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohns Disease According to First-of-its Kind Study
7. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
8. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
9. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
10. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
11. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... July 23, 2014 /PRNewswire-iReach/ -- Top Staten Island Pediatrician ... his feedback on article, which discusses tips for parents about ... According to US News ... death among American children aged 1 to 4, and can ... One expert in the article says that watching a ...
(Date:7/23/2014)... July 23, 2014 Inovio Pharmaceuticals, ... results from its randomized, double-blind, placebo-controlled phase ... biopsy-proven cervical intraepithelial neoplasia 2/3 (CIN2/3) associated ... 18. Treatment with VGX-3100, Inovio,s HPV16/18-specific immunotherapy, ... CIN1 or no disease, meeting the study,s ...
(Date:7/23/2014)... , July 23, 2014  The management team ... ) will hold a conference call on July ... second quarter ended June 30, 2014.  The call ... 2014Time: , 8:30 am EDTDial-in numbers: , Toll ... (412) 317-0790Webcast (live & archive): , www.columbialabs.com ...
Breaking Medicine Technology:Premier Staten Island Pediatrician Dr. Michael Gabriel Comments On Article Discussing Pool Safety Tips for Parents 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 3Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 4Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 5Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call 2
... , PALO ALTO, Calif., Dec. 2 ... 25, 2009, Varian, Inc. filed with the U.S. Securities and Exchange ... ended October 2, 2009. This Annual Report may be accessed ... and "SEC Filings," and then on "10-K" in the table shown. ...
... , ST. LOUIS, Dec. 2 KV Pharmaceutical Company ... an employment agreement with Interim President and Chief Executive Officer ... 2011. Mr. Van Vliet has served as Interim President and ... provides continuity of senior leadership as the Company seeks to ...
Cached Medicine Technology:KV Pharmaceutical Enters Into Employment Agreement with Interim President and Chief Executive Officer David A. Van Vliet 2
(Date:7/23/2014)... 23, 2014 Ticket Down is ... tickets in Dallas, TX at the Cotton Bowl. The ... held in the United States and Canada beginning on July ... teams from La Liga, Serie A, English Premier League, and ... United, Manchester City, Olympiacos, Inter Milan, Liverpool, AS Roma, and ...
(Date:7/23/2014)... Recently, Agebc.com has launched its new collection ... announcing a promotion of wedding dresses. According to a ... the end of this month. , The beautiful wedding ... A-line, mermaid, ball-gown, empire, and more. Agebc.com is a ... dresses for women, and the company is devoted to ...
(Date:7/23/2014)... A Forever Recovery, an open-ended drug and ... great start and gives them a solid foundation in ... Internet Addiction section of its website at http://aforeverrecovery.com/behavioral-addictions/internet-addiction/ ... Internet addiction is not just as legitimate a disorder ... trapping more and more victims each year – particularly ...
(Date:7/23/2014)... Karen Pallarito HealthDay Reporter ... day for Obamacare, two federal appeals courts arrived at completely ... to millions of Americans who bought health insurance through the ... matter is headed for a showdown before the U.S. Supreme ... Appeals Court for the District of Columbia Circuit said that ...
(Date:7/23/2014)... -- For critically ill patients arriving at the ... analgesia, sedation and amnesia for rapid, life-saving intubation, ... pressure. The results of a systematic review ... physicians regard as a "wonder drug" are published ... " The Effect of Ketamine on Intracranial and ...
Breaking Medicine News(10 mins):Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Slashes Ticket Prices on all AS Roma vs. Real Madrid International Champions Cup Tickets 2Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Slashes Ticket Prices on all AS Roma vs. Real Madrid International Champions Cup Tickets 3Health News:Agebc.com Launched Its New Collection of Wedding Dresses 2Health News:Latest A Forever Recovery Launches Internet Addiction Section on Website 2Health News:2 Courts, 2 Different Decisions on Key Obamacare Provision 2Health News:2 Courts, 2 Different Decisions on Key Obamacare Provision 3Health News:Ketamine can be a wonder drug for ER patients and their physicians 2
... , , ... Democrat in Arcadia, LA recently reported that ... in treating cancers, introducing many new, breakthrough medicines . ... 861 new cancer medicines that are either in late-stage testing, ...
... , , MINNEAPOLIS , Jan. 29 ... it will continue to support efforts to save the General Assistance ... in payments for services, since the existing payments already do not ... to support broad-based tax increases that would support health care programs. ...
... , Statement by Jim Wordelman State Director for AARP Idaho ... of Congress figure out the next steps to take to tackle health ... by the day.  It,s time for Idaho ,s state and federal ... businesses, and retirees to deliver solutions as opposed to more roadblocks to ...
... , LOS ANGELES , Jan. 29 In a ... the nation,s organ donation and transplant community will vote for the best ... Seven Pounds , Return to Me , John Q ... Philadelphia Transplant Movie Night, a group of transplant recipients, living donors and ...
... Bill & Melinda Gates Foundation announced it would dedicate ... vaccine research, development and delivery throughout the developing world. ... pneumonia, diarrhea and malaria take the lives of 5 ... simply because life-saving vaccines don,t reach those who need ...
... Project A.L.S. (New York, NY) and the Robert Packard ... MD) announced that they will partner on, P2 ALS, ... Gehrig,s disease) research exponentially over the next three years. ... leaders in forging productive collaborations among research scientists, will ...
Cached Medicine News:Health News:Cancer Medicines Pipeline Offers Patients Great Hope 2Health News:Doctors Tell Lawmakers to Find a New GAMC Fix 2Health News:Idaho's Health Care Woes Need Solutions, Not More Roadblocks 2Health News:Idaho's Health Care Woes Need Solutions, Not More Roadblocks 3Health News:Nationwide Vote to Determine Best Organ Donation-Themed Movie 2Health News:Project A.L.S. and Packard Center take aim at ALS with $15 million program 2
Diamond Filter Tips play a critical role in preventing aerosol-borne contamination. Also available sterilized (no need to autoclave) and certified free of detectable RNase, DNase, DNA, RNA, and prote...
10 L, Racked, Pre-sterilized, 96 tips/rack Recommended for 2, 5 and 10 L pipettes....
... are ideal for PCR and ... any work where aerosol contamination ... for pipetting DNA/RNA solutions, infectious ... For applications requiring absolute sterility, ...
Avant E-Z Rack Premium Low Binding 10 l Pipet Tips are accurate, contamination free, and allow quantitative transfer of your samples without relying on silicone....
Medicine Products: